Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Purab Pal
Observed name:
Pal, Purab
Institution:
University of Illinois Chicago
Observed institutions:
University of Calcutta,
Southern Illinois University Carbondale,
SIU Medicine,
University of Illinois Chicago
ORCID:
0000-0001-9065-2077
Observed ORCID:
0000-0001-9065-2077
OpenAlex ID:
A5019864786
Emerging Roles of Ceramides in Breast Cancer Biology and Therapy
2022
·
Purab Pal
, G. Ekin Atilla-Gokcumen
, et al.
·
International Journal of Molecular Sciences
·
48
PDF
Pro-apoptotic and anti-angiogenic actions of 2-methoxyestradiol and docosahexaenoic acid, the biologically derived active compounds from flaxseed diet, in preventing ovarian cancer
2019
·
Purab Pal
, Karen Hales
, et al.
·
Journal of Ovarian Research
·
40
PDF
A Review of Principal Studies on the Development and Treatment of Epithelial Ovarian Cancer in the Laying Hen Gallus gallus
2021
·
Purab Pal
, Kara Nicole Starkweather
, et al.
·
Comparative Medicine
·
23
Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells
2022
·
Svetlana E. Semina
, Purab Pal
, et al.
·
Breast Cancer Research
·
19
PDF
Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells
2022
·
Purab Pal
, Alec Millner
, et al.
·
Cancers
·
17
PDF
The pro-apoptotic actions of 2-methoxyestradiol against ovarian cancer involve catalytic activation of PKCδ signaling
2020
·
Purab Pal
, Karen Hales
, et al.
·
Oncotarget
·
5
PDF
Structural analysis of sigma E interactions with core RNA polymerase and its cognate P-hsp20promoter ofMycobacterium tuberculosis
2015
·
Aayatti Mallick Gupta
, Purab Pal
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
4
Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
·
Molecular Cancer Research
·
1
Supplementary Figure S4 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S3 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S9 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S10 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S1 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S2 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S5 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S5 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S2 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S11 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S10 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S6 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S8 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S9 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Data from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S4 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S3 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Show more works
View as search
Works count:
47
Citation count:
157
H-index:
5
I10-index:
5
Year
Topic
Type